{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:55:17Z","timestamp":1791309317248,"version":"4.3.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.encep.2008.10.014","type":"journal-article","created":{"date-parts":[[2009,7,10]],"date-time":"2009-07-10T08:34:11Z","timestamp":1247214851000},"page":"330-339","source":"Crossref","is-referenced-by-count":84,"title":["\u00c9laboration de recommandations pour le suivi somatique des patients atteints de pathologie mentale s\u00e9v\u00e8re"],"prefix":"10.1016","volume":"35","author":[{"given":"D.","family":"Saravane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Feve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Frances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Corruble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lancon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Maison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Terra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Azorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2008.10.014_bib1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome: a worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2008.10.014_bib2","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2008.10.014_bib3","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"7","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.encep.2008.10.014_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0269881107075509","article-title":"Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity, and dyslipidaemia","volume":"21","author":"Barnett","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.encep.2008.10.014_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/bjp.177.3.212","article-title":"Causes of the excess of mortality in schizophrenia","volume":"177","author":"Brown","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2008.10.014_bib6","first-page":"329","article-title":"Mortality in schizophrenic patients, 3 years follow-up of a cohort","volume":"25","author":"Casadebaig","year":"1999","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2008.10.014_bib7","doi-asserted-by":"crossref","unstructured":"CSISG. Minimizing the risks associated with significant QT prolongation in people with schizophrenia: a consensus statement by the Cardiac Safety in Schizophrenia Group. Austr Psychiatry 2002;10:115\u201324.","DOI":"10.1046\/j.1440-1665.2002.00419.x"},{"key":"10.1016\/j.encep.2008.10.014_bib8","unstructured":"Covel NH, Jackson CT, & Weissman EM. Health monitoring for patients who have schizophrenia. Summary of the Mount Sinai Conference recommendations. Postgrad Med 2006; spec. N\u00b0 20\u20136."},{"key":"10.1016\/j.encep.2008.10.014_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-0179-2-14","article-title":"Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study","volume":"2","author":"De Hert","year":"2006","journal-title":"Clin Pract Epidemol Ment Health"},{"key":"10.1016\/j.encep.2008.10.014_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/13651500510018310","article-title":"Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics","volume":"9","author":"De NayerA","year":"2005","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.encep.2008.10.014_bib11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1399-5618.2005.00234.x","article-title":"Metabolic syndrome in bipolar disorder: findings from the Bipolar Center for Pennsylvanians","volume":"7","author":"Faglioni","year":"2005","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.encep.2008.10.014_bib12","first-page":"62","article-title":"Antipsychotiques et s\u00e9curit\u00e9 cardiovasculaires\u00a0: donn\u00e9es actuelles sur les allongements de l\u2019intervalle QT et le risque d\u2019arythmies ventriculaires","volume":"XXVI","author":"Gury","year":"2000","journal-title":"Enc\u00e9phale"},{"key":"10.1016\/j.encep.2008.10.014_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-244X-7-28","article-title":"A prospective study of monitoring practices for metabolic diseases in anti-psychotic treated community psychiatric patients","volume":"7","author":"Mackin","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.encep.2008.10.014_bib14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-9964(01)00325-5","article-title":"Neuroleptics and mortality in schizophrenia\u00a0: prospective analysis of deaths in a French cohort of schizophrenic patients","volume":"57","author":"Montout","year":"2002","journal-title":"Schizophren Res"},{"key":"10.1016\/j.encep.2008.10.014_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1192\/bjp.163.2.183","article-title":"Mortality and causes of death in first admitted schizophrenic patients","volume":"163","author":"Mortensen","year":"1993","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2008.10.014_bib16","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(89)91392-5","article-title":"Family history of type 2 diabetes in schizophrenic patients","volume":"8636","author":"Mukherjee","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2008.10.014_bib17","series-title":"Paper presented at ACNP 44th Annual Meeting","article-title":"Low rate of treatment for metabolic disorders in the CATIE schizophrenia trial at baseline: healthcare disparities in schizophrenia","author":"Nasrallah","year":"2005"},{"key":"10.1016\/j.encep.2008.10.014_bib18","first-page":"S20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Pschiatry"},{"key":"10.1016\/j.encep.2008.10.014_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/070674370505000909","article-title":"Atypical antipsychotics in psychiatric practice: practical implications for clinical monitoring","volume":"50","author":"Poulin","year":"2005","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2008.10.014_bib20","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","article-title":"QTC-interval abnormalities and psychiatric drug therapy in psychiatric patients","volume":"355","author":"Reilly","year":"2000","journal-title":"The Lancet"},{"key":"10.1016\/j.encep.2008.10.014_bib21","doi-asserted-by":"crossref","unstructured":"Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Aust N Z J Psychiatry 2005;39:1\u201330.","DOI":"10.1080\/j.1440-1614.2005.01516.x"},{"key":"10.1016\/j.encep.2008.10.014_bib22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0024-3205(02)01646-6","article-title":"Physical consequences of schizophrenia and its treatment: the metabolic syndrome","volume":"71","author":"Ryan","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.encep.2008.10.014_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first episode, drug-na\u00efve patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"Am J Psychatry"},{"key":"10.1016\/j.encep.2008.10.014_bib24","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1001\/archinte.160.12.1761","article-title":"Association between depression and mortality in older adults: the Cardiovascular Health Study","volume":"160","author":"Schulz","year":"2000","journal-title":"Arch Int Med"},{"key":"10.1016\/j.encep.2008.10.014_bib25","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-244X-7-14","article-title":"Metabolic syndrome in Thai schizophrenic patients: a naturalistic one year follow-up study","volume":"7","author":"Srisurapanont","year":"2007","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.encep.2008.10.014_bib26","first-page":"152","article-title":"The metabolic syndrome in patients with severe mental illness Prim Care Companion J","volume":"6","author":"Toalson","year":"2004","journal-title":"Clin Psychiatry"},{"key":"10.1016\/j.encep.2008.10.014_bib27","first-page":"111","article-title":"Canadian Association position paper: antipsychotic medications and associated risks of weight gain and diabetes","volume":"29","author":"Woo","year":"2005","journal-title":"Can J Diab"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700609000992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700609000992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T23:24:14Z","timestamp":1685057054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700609000992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0013700609000992"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2008.10.014","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}